Cargando…

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Detalles Bibliográficos
Autores principales:	Smith, Robert Løvsletten, O’Connell, Kevin, Athanasiu, Lavinia, Djurovic, Srdjan, Kringen, Marianne Kristiansen, Andreassen, Ole A., Molden, Espen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608619/ https://www.ncbi.nlm.nih.gov/pubmed/33139722 http://dx.doi.org/10.1038/s41398-020-01061-4

Ejemplares similares

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020)

Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)

Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients
por: Kyllesø, Lennart, et al.
Publicado: (2021)

Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
por: Kyllesø, Lennart, et al.
Publicado: (2020)

Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment: A Retrospective Pilot Study
por: Kyllesø, Lennart, et al.
Publicado: (2022)

Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype
por: Wollmann, Birgit M., et al.
Publicado: (2023)

Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank
por: O'Connell, Kevin S., et al.
Publicado: (2022)

Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response
por: Akkouh, Ibrahim A, et al.
Publicado: (2021)

Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population
por: Bråten, Line Skute, et al.
Publicado: (2022)

Telomere length is associated with childhood trauma in patients with severe mental disorders
por: Aas, Monica, et al.
Publicado: (2019)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
por: Johannsen, Claas-Frederik, et al.
Publicado: (2022)

Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2019)

Alterations in Schizophrenia-Associated Genes Can Lead to Increased Power in Delta Oscillations
por: Mäki-Marttunen, Tuomo, et al.
Publicado: (2019)

Using iPSC Models to Understand the Role of Estrogen in Neuron–Glia Interactions in Schizophrenia and Bipolar Disorder
por: Reis de Assis, Denis, et al.
Publicado: (2021)

Impairment of endoxifen formation in tamoxifen‐treated premenopausal breast cancer patients carrying reduced‐function CYP2D6 alleles
por: Thorén, Linda, et al.
Publicado: (2020)

Cross-tissue eQTL enrichment of associations in schizophrenia
por: Bettella, Francesco, et al.
Publicado: (2018)

Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking
por: Hindley, Guy, et al.
Publicado: (2021)

Probing the Association between Early Evolutionary Markers and Schizophrenia
por: Srinivasan, Saurabh, et al.
Publicado: (2017)

Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders
por: Haram, Marit, et al.
Publicado: (2015)

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
por: Szabo, Attila, et al.
Publicado: (2020)

Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)

The estrogen hypothesis of Schizophrenia implicates glucose metabolism: Association study in three independent samples
por: Olsen, Line, et al.
Publicado: (2008)

Genome-wide Association Analysis of Schizophrenia and Vitamin D Levels Shows Shared Genetic Architecture and Identifies Novel Risk Loci
por: Jaholkowski, Piotr, et al.
Publicado: (2023)

Genetic associations with clozapine-induced myocarditis in patients with schizophrenia
por: Lacaze, Paul, et al.
Publicado: (2020)

Genetic variation in 117 myelination-related genes in schizophrenia: Replication of association to lipid biosynthesis genes
por: Stokowy, Tomasz, et al.
Publicado: (2018)

Genetic mechanisms for impaired synaptic plasticity in schizophrenia revealed by computational modelling
por: Mäki-Marttunen, Tuomo, et al.
Publicado: (2023)

Vitamin D levels, brain volume, and genetic architecture in patients with psychosis
por: Berg, Akiah Ottesen, et al.
Publicado: (2018)

Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia
por: Lindholm Carlström, Eva, et al.
Publicado: (2012)

Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
por: Kikuchi, Yuki, et al.
Publicado: (2023)

Contribution of oxytocin receptor polymorphisms to amygdala activation in schizophrenia spectrum disorders
por: Haram, Marit, et al.
Publicado: (2016)

The impact of placental genomic risk for schizophrenia and birth asphyxia on brain development
por: Wortinger, Laura A., et al.
Publicado: (2023)

Genome-Wide Analysis of Attention Deficit Hyperactivity Disorder in Norway
por: Zayats, Tetyana, et al.
Publicado: (2015)

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
por: Eryılmaz, Gül, et al.
Publicado: (2013)

M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

Expression of TCN1 in Blood is Negatively Associated with Verbal Declarative Memory Performance
por: Akkouh, Ibrahim A., et al.
Publicado: (2018)

Polygenic scores for schizophrenia and general cognitive ability: associations with six cognitive domains, premorbid intelligence, and cognitive composite score in individuals with a psychotic disorder and in healthy controls
por: Engen, Magnus Johan, et al.
Publicado: (2020)

CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls
por: Tesli, Martin, et al.
Publicado: (2013)

Towards "biophysical psychiatry": a modeling approach for studying effects of schizophrenia-linked genes on single-neuron excitability
por: Mäki-Marttunen, Tuomo, et al.
Publicado: (2015)

Phenotype‐informed polygenic risk scores are associated with worse outcome in individuals at risk of Alzheimer's disease
por: Nordengen, Kaja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mhmkib3h7ttivl6s027a4hu39s